Silence Therapeutics (SLN) Gross Margin (2024 - 2026)
Silence Therapeutics (SLN) posted Gross Margin of 97.39% for Q1 2026, up 50.52% sequentially from 64.71% in Q4 2025, and up 3542.0% YoY from 2.67% in Q1 2025.
Silence Therapeutics (SLN) Gross Margin (2024 - 2026) Analysis & Trends
Silence Therapeutics has reported Gross Margin for 3 years, with the latest figure at 97.39% in Q1 2026.
- Quarterly Gross Margin rose 3542.0% year-over-year to 97.39% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 79.5% (up 1233.0% YoY) and the FY2025 annual result came in at 61.54%, down 1116.0% from the prior year.
- Gross Margin advanced to 97.39% in Q1 2026 per SLN's latest filing, from 64.71% in the prior quarter.
- Over five years, Gross Margin peaked at 97.39% in Q1 2026 and troughed at 322.12% in Q2 2024.
- A 3-year average of 6.1% and a median of 62.05% in 2025 frame the typical range for Gross Margin.
- The widest YoY moves for Gross Margin: up 38418 bps in 2025, down 2724 bps in 2025.
- Over 3 years, Gross Margin stood at 91.95% in 2024, then decreased by 30 bps to 64.71% in 2025, then soared by 51 bps to 97.39% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 97.39%, 64.71%, and 59.75% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 90.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 89.76% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 60,631,834.75% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 76.90% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 84.20% |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.39% |
| Dec 31, 2025 | 64.71% |
| Sep 30, 2025 | 59.75% |
| Jun 30, 2025 | 62.05% |
| Mar 31, 2025 | 61.97% |
| Dec 31, 2024 | 91.95% |
| Sep 30, 2024 | -142.92% |
| Jun 30, 2024 | -322.13% |
| Mar 31, 2024 | 82.16% |